Home | Welcome to Contract Pharma   
Last Updated Wednesday, June 19 2013
Print RSS Feed

Breaking News

Related Searches:
Aptuit Acquires GSK Research Site

July 1, 2010
GlaxoSmithKline and Aptuit, Inc. have finalized an agreement for Aptuit to acquire operations at GSK’s Medicines Research Centre in Verona, Italy.  Read More »
Eisai, Arena in Marketing and Supply Pact

July 1, 2010
Eisai Inc., the U.S. operation of Tokyo-based Eisai Co., Ltd., has entered into an agreement with Arena Pharmaceuticals for exclusive U.S. rights to commercialize lorcaserin, a drug candidate for potential treatment of obesity, including weight loss.  Read More »
Biogen Idec

July 1, 2010
George A. Scangos, Ph.D. has been appointed chief executive officer of Biogen Idec, effective July 15.  Read More »
Sanofi-Aventis To Acquire TargeGen

July 1, 2010
Sanofi-aventis has entered an agreement to acquire TargeGen, Inc., a privately held biotechnology company focused on the development of small molecule kinase inhibitors.   Read More »
JHP Enters Multi-Year Manufacturing Pact

June 30, 2010
JHP Pharmaceuticals has entered into a multi-year contract supply agreement with an undisclosed ophthalmic company.   Read More »
Celgene To Acquire Abraxis

June 30, 2010
Celgene Corp. and Abraxis BioScience have signed a definitive merger agreement under which Celgene will acquire Abraxis for approximately $2.9 billion.  Read More »
ICON Opens New Lab in China

June 30, 2010
ICON Central Laboratories has opened a new lab facility in Tianjin, China, in partnership with Fountain Medical Development Ltd. (FMD).  Read More »
DPT Laboratories, Ltd.

June 29, 2010
Tom Mitchell has been promoted to senior manager of marketing at DPT Laboratories, Ltd.   Read More »
Catalent Director Becomes USP Member

June 29, 2010
Stephen Tindal, director, Softgel Formulation and Operations for Catalent Pharma Solutions, has been accepted as a member of the United States Pharmacopoeia (USP) advisory panel focusing on liquid filled gelatin capsules.  Read More »
Teva Gains Approval for Effexor Generic

June 29, 2010
Teva Pharmaceutical Industries, Ltd. received approval from the FDA for Venlafaxine HCl ER Capsules, the company’s generic version of Wyeth’s antidepressant Effexor XR.  Read More »
Almac to Build Cold Storage Units at Headquarters

June 28, 2010
Almac’s new North American headquarters facility will feature a 271,000 cubic-foot cold storage unit to accommodate clinical supplies, in particular biologics.  Read More »
MorphoSys, Xencor Enter Antibody Pact

June 28, 2010
MorphoSys AG and Xencor, Inc. have signed an exclusive worldwide license and collaboration agreement for an antibody in Phase I development.   Read More »
Gilead To Acquire CGI Pharma

June 25, 2010
Gilead Sciences and CGI Pharmaceuticals, Inc. have entered into a definitive agreement under which Gilead will acquire CGI for as much as $120 million—the majority as an upfront payment and the rest based on clinical development progress.  Read More »
Lancaster Laboratories

June 25, 2010
Jeri Ann Boose, Ph.D. has joined Lancaster Laboratories as director of Biopharmaceutical Services.   Read More »
Saltigo Successfully Completes FDA Audit

June 25, 2010
Saltigo GmbH has passed an FDA audit at its Leverkusen site.   Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:

Follow Contract Pharma On
Please visit our sister sites: